Bumper Offer - Urjas oil Just @ Rs. 1
Duovir Tablet (60) is a commercial drug that is prescribed in the form of Tablet. Other than this, Duovir Tablet (60) has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Duovir Tablet (60). The condition it has been prescribed for, and the route of administration also determine the right dosage. Detailed information has been provided in the dosage section.
Apart from the aforementioned side effects, Duovir Tablet (60) can also lead to other problems, which have been listed below. Usually, these side effects of Duovir Tablet (60) go away soon, and do not persist beyond the duration of the treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.
It is also important to note that Duovir Tablet (60) has a Moderate effect for pregnant women and Moderate effect on lactating mothers. In addition, Duovir Tablet (60)'s effects on the liver, heart and kidney are discussed below in the Duovir Tablet (60) related warnings section.
Duovir Tablet (60) is not recommended if you suffer from certain medical conditions as it can have adverse effects. Kidney Disease, Pancreatitis, Kidney Disease are examples of such conditions. The section on Duovir Tablet (60) contraindications lists all such conditions.
Drug interactions for Duovir Tablet (60) have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Duovir Tablet (60), it is important to know that it is not safe while driving, and is not habit-forming.
Duovir Tablet (60) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Duovir Tablet (60) is used -
Moderate
Mild
Is the use of Duovir Tablet (60) safe for pregnant women?
Duovir may have some side effects during pregnancy. Pregnant women should discontinue the use of Duovir, and talk to their doctor, if they notice any discomfort.
Is the use of Duovir Tablet (60) safe during breastfeeding?
Breastfeeding women may feel side effects of Duovir. If you see any side effects, stop taking Duovir immediately and talk to your doctor. Take Duovir again, only after your doctor's advice.
What is the effect of Duovir Tablet (60) on the Kidneys?
Duovir has very mild side effects on the kidneys.
What is the effect of Duovir Tablet (60) on the Liver?
Duovir is rarely harmful for the liver.
What is the effect of Duovir Tablet (60) on the Heart?
Duovir is rarely harmful for the heart.
Duovir Tablet (60) should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Duovir Tablet (60) unless your doctor advises you to do so -
Is this Duovir Tablet (60) habit forming or addictive?
Duovir Tablet (60) does not cause addiction.
Interaction between Food and Duovir Tablet (60)
Taking Duovir Tablet (60) with food is safe.
Interaction between Alcohol and Duovir Tablet (60)
Taking alcohol with Duovir Tablet (60) can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Epivir (lamivudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 807-808
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 96-99
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Retrovir® (zidovudine)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 806-807
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1286-1288
